Jupiter Research Capital (Asia) Ltd’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
Jupiter Research Capital (Asia) Ltd's PTCT Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in PTC Therapeutics (PTCT) in Q3 2026: 6,081 shares worth $394K. The stake represents 0.04% of the portfolio and ranks #406 among its holdings.
350 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 6,081 shares of PTC Therapeutics worth $394K as of Q3 2026.
- PTC Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- PTC Therapeutics made up 0.04% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #406 holding.
- 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.